BioHealth News Archive
CARB-X 2018 Funds
Are you involved in the fight against drug resistant bacteria? Between June 1 and June 8th, organizations seeking funding to advance antimicrobial technologies (diagnostics,…
Read More
BioHealth Capital Region Industry Compensation Survey™
Is your employee compensation package competitive? Help us help you. Complete the 2018 BHCR Industry Compensation Survey by June 1, 2018 to receive an anonymized summary…
Read More
MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
MaxCyte, the global cell-based medicines and life sciences company, announced today that it has appointed Claudio Dansky Ullmann, MD, a 25+-year expert in clinical…
Read More
Corvidia Therapeutics Secures $60 Million in Series B Funding to Accelerate Clinical Work | Business Wire
Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, today announced the close of a $60 million USD Series B funding round. The financing…
Read More
Commercialization Brings Research with ‘Broad Benefits’ to Market – GW Today
Patients dealing with hypotension, or dangerously low blood pressure, can now be treated with a drug initially developed by George Washington University researcher Lakhmir Chawla from the School…
Read More
A ‘groundbreaking’ day: Workers break ground on new science complex
Towson University celebrated the start of construction on the new science complex with a groundbreaking ceremony on the top floor of the Glen Garage…
Read More
Message at BioHealth forum: Md., Va., and D.C. biotech industry needs to get rid of silos – Baltimore Business Journal
The annual BioHealth forum brought together about 1,100 biotech industry stakeholders from across Maryland, Washington, D.C., and Virginia. {iframe}https://www.bizjournals.com/baltimore/news/2018/04/23/message-at-biohealth-forum-md-va-and-d-c-biotech.html{/iframe}
Read More
University presidents Loh, Perman on impact of immigration changes to STEM workforce – Baltimore Business Journal
George Mason University President Angel Cabrera said more restrictive immigration policies could threaten the future of regional and national biotechnology industries. “It is critical…
Read More
Science Start-Ups Gain Strong Momentum at the Prince William Science Accelerator – pilotonline.com
Prince William County today congratulated three science start-ups – ISOThrive, LLC, Virongy, LLC and Ceres Nanosciences, Inc., – on recent business successes leading from…
Read More
Emmes Launches New Internship Program with an Egyptian Children’s Cancer Hospital
The Emmes Corporation today announced the creation of an internship program in which the company will offer one fellow from Egypt's Children Cancer Hospital…
Read More
Q Therapeutics Announces Joint Venture With REPROCELL
Q Therapeutics, Inc., a developer of clinical-stage cell therapies for central nervous system (CNS) diseases, and REPROCELL Inc., Japan’s first induced pluripotent stem cell…
Read More
How New York VC firm Deerfield Management plans to help Johns Hopkins bring more products to market – Baltimore Business Journal
New York investment firm Deerfield Management is looking to bring more drugs, medical devices and health care products to market by partnering with academic…
Read More
QIAGEN Announces FDA Approval of PartoSureTM – Business Wire
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of PartoSureTM , which is a novel test for assessing…
Read More
Why you need to know NEA’s Scott Frederick – Washington Business Journal
He is a walking Rolodex of some of the nation’s most high-powered business leaders. And he’s the reason many startups feel they’ve gotten a…
Read More
Chinese money floods US biotech as Beijing chases new cures | afr.com
Chinese investors are pumping money into US drug startups as Beijing seeks to become a global leader in new medicines, adding to a flood of…
Read More